Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Monoclonal antibodies that block immune regulatory proteins such as programmed death-1 (PD-1) have demonstrated remarkable efficacy in controlling the growth of multiple tumor types. Unresectable or metastatic basal cell carcinoma, however, has largely gone untested. Because PD-Ligand-1 (PD-L1) expr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Immunother Cancer
Главные авторы: Lipson, Evan J., Lilo, Mohammed T., Ogurtsova, Aleksandra, Esandrio, Jessica, Xu, Haiying, Brothers, Patricia, Schollenberger, Megan, Sharfman, William H., Taube, Janis M.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Short Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5360064/
https://ncbi.nlm.nih.gov/pubmed/28344809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0228-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы